NLG919
CAS: 1402836-58-1
Ref. 3D-FN137701
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
Name:
NLG919
Description:
NLG919 is a small molecule that inhibits the enzyme IDO1, which is responsible for the breakdown of tryptophan. This inhibition results in increased levels of tryptophan and increased production of tumor necrosis factor-α (TNF-α), which has been shown to have significant cytotoxicity on prostate cancer cells. NLG919 also has potential to be an immunotherapy agent, as it induces antibodies against tumor cells. The proposed mechanism of action for NLG919 is based on its ability to inhibit IDO1 and TNF-α production, which can lead to tumor regression.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
282.38 g/mol
Formula:
C18H22N2O
Purity:
Min. 95%
Color/Form:
Solid
InChI:
InChI=1S/C18H22N2O/c21-18(13-6-2-1-3-7-13)10-16-14-8-4-5-9-15(14)17-11-19-12-20(16)17/h4-5,8-9,11-13,16,18,21H,1-3,6-7,10H2
InChI key:
InChIKey=YTRRAUACYORZLX-UHFFFAOYSA-N
SMILES:
OC(CC1c2ccccc2-c2cncn21)C1CCCCC1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
